No Data
No Data
Tonix Pharmaceuticals Achieves Key Milestone With FDA Review Timeline for Innovative Fibromyalgia Treatment | NASDAQ:TNXP
Trending Stocks Today | Nocera Surges 63.95% Post-Market
Tonix Pharmaceuticals Announces PDUFA Goal Date Of August 15, 2025, For FDA Decision On U.S. Marketing Approval For TNX-102 SL For Fibromyalgia
Express News | Tonix Pharmaceuticals Announces Pdufa Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for Tnx-102 Sl for Fibromyalgia
Trending Stocks Today | Brenmiller Energy Shoots up 40.71% Post-Market
Express News | Tonix Pharmaceuticals Holding Corp - Increases Maximum Aggregate Offering Price to $250 Million
No Data